Metastasis-directed Therapy in solitary oligorecurrent Prostate Cancer without Androgen Deprivation Therapy - a Commentary

被引：0
|
作者：
Falkenbach, Fabian [1 ,3 ]
Maurer, Tobias [1 ,2 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Martini Klin Prostatakarzinomzentrum, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Urol, Hamburg, Germany
[3] Univ Klinikum Hamburg Eppendorf, Martini Klin Prostatakarzinomzentrum, Martinistr 52, D-20246 Hamburg, Germany
来源：
UROLOGIE | 2023年 / 62卷 / 04期
关键词：
PREDICTORS; RECURRENCE; DIAGNOSIS; PET/CT;
D O I：
10.1007/s00120-023-02050-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 406
页数：3
相关论文
共 50 条
  • [41] Metastasis-Directed Therapy influence in clinical outcomes of oligorrecurrent prostate cancer
    Gonzalez Lopez, A.
    Buchser, D.
    Suarez, F.
    Mayrata, E.
    Casquero, F.
    Bilbao, P.
    Gomez-Iturriaga, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S621 - S622
  • [42] THE ROLE OF METASTASIS-DIRECTED THERAPY IN THE JOURNEY OFOLIGOMETASTATIC PROSTATE CANCER PATIENTS
    Mastroleo, Federico
    Villa, Riccardo
    Colombi, Lorenzo
    Milovanova, Ekaterina
    Zamboglou, Costantinos
    Luzzago, Stefano
    Mistretta, Francesco Alessandro
    Alessi, Sarah
    Petralia, Giuseppe
    Carrafiello, Gianpaolo
    Musi, Gennaro
    De Cobelli, Ottavio
    Vincini, Maria Giulia
    Zaffaroni, Mattia
    Franco, Pierfrancesco
    Marvaso, Giulia
    Jereczek-Fossa, Barbara Alicja
    ANTICANCER RESEARCH, 2024, 44 (10)
  • [43] Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter to the editor
    L. Triggiani
    D. Tomasini
    R. Mazzola
    Medical Oncology, 2021, 38
  • [44] Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.
    Cem Onal
    Ezgi Oymak
    Ozan Cem Guler
    Medical Oncology, 2021, 38
  • [45] PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancer
    Ambrosini, Francesca
    Koehler, Daniel
    Ghadban, Tarik
    Jacobsen, Frank
    Knipper, Sophie
    von Amsberg, Gunhild
    Steuber, Thomas
    Maurer, Tobias
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2023, 76 (03) : 182 - 185
  • [46] Clinical outcomes of metastasis-directed radiation therapy (MDRT) for oligometastatic prostate cancer
    Tabata, Ken-ichi
    ANNALS OF ONCOLOGY, 2021, 32 : S315 - S315
  • [47] Is there a role for metastasis-directed therapy in bladder cancer?
    Abufaraj, Mohammad
    Al Karmi, Joud
    Bdeir, Adan
    CURRENT OPINION IN UROLOGY, 2024, 34 (04) : 273 - 280
  • [48] Metastasis-directed therapy for oligometastases in breast cancer
    Ishiba, Toshiyuki
    Nishibuchi, Ikuno
    Hara, Fumikata
    Shikama, Naoto
    Shien, Tadahiko
    Iwata, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (10) : 893 - 898
  • [49] The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
    Kim, Jongchan
    Park, Jee Soo
    Ham, Won Sik
    INVESTIGATIVE AND CLINICAL UROLOGY, 2017, 58 (05) : 307 - 316
  • [50] Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer
    Voog, Justin C.
    Smith, Matthew R.
    Efstathiou, Jason A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (10): : 1054 - 1055
12345